What's new

Referral: Mysimba, naltrexone,bupropion Article 20 procedures European Commission final decision, 27/03/2025, 22/05/2025, 03/06/2025

Referral: Mysimba, naltrexone,bupropion Article 20 procedures European Commission final decision, 27/03/2025, 22/05/2025, 03/06/2025

Jun 3, 2025 - 16:20
 0
Referral: Mysimba, naltrexone,bupropion Article 20 procedures European Commission final decision, 27/03/2025, 22/05/2025, 03/06/2025
Referral: Mysimba, naltrexone,bupropion Article 20 procedures European Commission final decision, 27/03/2025, 22/05/2025, 03/06/2025
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Mysimba, naltrexone,bu...

Next Article

Human medicines European public assessment report (EPAR): Atropine sulfate FGK, ...

Related Posts

Human medicines European public assessment report (EPAR): Pyzchiva, ustekinumab, Date of authorisation: 19/04/2024, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR...

May 26, 2025  0

European Shortages Monitoring Platform (ESMP): National...

May 13, 2025  0

Human medicines European public assessment report (EPAR): Prasugrel Viatris (previously Prasugrel Mylan), prasugrel, Date of authorisation: 15/05/2018, Revision: 12, Status: Authorised

Human medicines European public assessment report (EPAR...

Jun 2, 2025  0